In the new research, we claimed the identification as well as the characterization of a different atypical opioid receptor with unique adverse regulatory Homes in direction of opioid peptides.1 Our final results confirmed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a wide-spectrum